Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.

AUSTIN, Texas, Oct. 15 Luminex Corporation(Nasdaq: LMNX) today announced that it has settled the pending litigation withRules Based Medicine, Inc ("RBM"). As part of the settlement, Luminexreceived a cash payment of $12.5 million. The cash payment was made by RBM inexchange for resolution of the dispute between the companies regardingBiophysical Corporation as well as the retirement of Luminex's stock ownershipin RBM and the grant of certain additional licensing rights from Luminex. Allother terms of the agreement are confidential. The parties intend to formallydismiss the lawsuit, as required by the Settlement Agreement.

Luminex Corporation develops, manufactures and markets proprietarybiological testing technologies with applications throughout the life sciencesindustry. The Company's xMAP(R) system is an open-architecture, multi-analytetechnology platform that delivers fast, accurate and cost-effective bioassayresults to markets as diverse as pharmaceutical drug discovery, clinicaldiagnostics and biomedical research, including the genomics and proteomicsresearch markets. The Company's xMAP technology is sold worldwide and is inuse in leading research laboratories as well as major pharmaceutical,diagnostic and biotechnology companies. Further information on LuminexCorporation or xMAP can be obtained on the Internet athttp://www.luminexcorp.com .Contact: Harriss T. Currie Vice President, Finance and Chief Financial Officer 512-219-8020 [email protected]

SOURCE Luminex Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...